Moneycontrol PRO

business

Pharma M&A: Why has IMG proposed stiff riders?

The inter-ministerial group that was set up to clear FDI in pharma brownfield projects has come out with stringent guidelines that could impact pharma mergers and acquisitions in India, reports CNBC-TV18's Ronojoy Banerjee.

first published: Jun 21, 2012 07:46 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347